FAK in NSCLC is suppressed via EGFR, and downregulation of IGF1R and integrin; in SCLC, suppression is achieved via downregulation of MET and EGFR; therefore, the model predicts that FAK expression has no difference in NSCLC and SCLC. Here, MET is linked to small cell lung carcinoma.